Factors influencing survival after resection for periampullary neoplasms
Autor: | David W. Easter, Reza A. Gamagami, Michael Bouvet, A. R. Moossa, Aaron R. Sasson, Elizabeth A. Gilpin, Oreste Romeo |
---|---|
Rok vydání: | 2000 |
Předmět: |
Adult
Male Ampulla of Vater medicine.medical_specialty Palliative care Biopsy medicine.medical_treatment Common Bile Duct Neoplasms Cystadenoma Cystadenocarcinoma Gastroenterology Pancreaticoduodenectomy Pancreatectomy Duodenal Neoplasms Internal medicine Pancreatic cancer medicine Humans Survival rate Aged Neoplasm Staging Aged 80 and over Analysis of Variance Laparotomy Common bile duct business.industry Anastomosis Surgical Palliative Care Cancer General Medicine Middle Aged medicine.disease Surgery Pancreatic Neoplasms Survival Rate Neuroendocrine Tumors medicine.anatomical_structure Lymphatic Metastasis Multivariate Analysis Female Duodenal cancer business Forecasting |
Zdroj: | The American Journal of Surgery. 180:13-17 |
ISSN: | 0002-9610 |
Popis: | Background: The purpose of this study was to determine predictors of survival after resection for periampullary neoplasms. Methods: Over a 15-year period, 208 patients underwent laparotomy for periampullary neoplasms. Data were analyzed to assess predictors of survival. Results: Pathologic examination showed pancreatic cancer (n = 136; 65%), ampullary cancer (n = 28; 13%), distal common bile duct cancer (n = 10; 5%), duodenal cancer (n = 4; 2%), neuroendocrine tumor (n = 11; 5%), cystadenocarcinoma (n = 4; 2%), cystadenoma (n = 5; 2%), and other (n = 10; 5%). A total of 129 patients underwent pancreatic resection (71 Whipples, 35 total pancreatectomies, 21 distal pancreatectomies, and 2 partial pancreatectomies) whereas 79 patients were found to be unresectable and underwent palliative bypass and/or biopsy. Median survival was 20.4 months for resectable patients versus 4.5 months for unresectable patients (P |
Databáze: | OpenAIRE |
Externí odkaz: |